ArticleBiomedicines2022

Evaluation of the Effectiveness of BNT162b2 Primary Vaccination and Booster Dose to SARS-CoV-2 in Eliciting Stable Mucosal Immunity.

Alessandro Lambiase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.